EMEA-001344-PIP01-12

Key facts

Active substance
  • Ezetimibe
  • Rosuvastatin
Therapeutic area
Cardiovascular diseases
Decision number
P/0271/2012
PIP number
EMEA-001344-PIP01-12
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
Zentiva, k.s.
Czech Republic
blanka.zoubkova@zentiva.com
Tel. +42 0267243574
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating